C062P: Relatlimab Biosimilar, Human LAG-3 Monoclonal Antibody

Recombinant Humanized IgG4 Monoclonal Antibody.
Specificity/Sensitivity: The research grade relatlimab biosimilar specifically binds to the human lymphocyte-activation gene 3 (LAG-3).
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by relatlimab.

C024P: Atezolizumab Biosimilar, PD-L1 Monoclonal Antibody

Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade atezolizumab biosimilar specifically binds to the human PDL1 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by atezolizumab.

PA006655-PA1740: TLR3 Polyclonal Antibody

Rabbit Polyclonal Antibody;
Applications: WB;
Reactivity: Human, Rat, Mouse;
Isotype: Rabbit IgG.

C035P: Spartalizumab Biosimilar, PD-1 Monoclonal Antibody

Recombinant Humanized IgG4 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade spartalizumab biosimilar specifically binds to the programmed cell death protein 1 (PD-1), antagonizing its interaction with its known ligands PD-L1 and PD-L2.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by spartalizumab.

PA008004.m2cLA: In Vivo Grade Recombinant Anti-mouse PD-1 / PD-L1 Bispecific Antibody, Mouse IgG2c LALAPG Kappa (Clone 29F.1A12.1 / 10F.9G2.1)

The in vivo grade recombinant anti-mouse PD-1 / PD-L1 bispecific antibody (mouse IgG2c-LALAPG kappa) was produced in mammalian cells.
Applications: immunohistochemistry (IHC), Flow Cytometry (FC), and various in vitro and in vivo functional assays.
Endotoxin Level: Less than 1 EU/mg of protein as determined by LAL method.

PA008005.m2cLA: In Vivo Grade Recombinant Anti-mouse PD-L1 / PD-1 Bispecific Antibody, Mouse IgG2c LALAPG Kappa (Clone 10F.9G2.1 / 29F.1A12.1)

The in vivo grade recombinant anti-mouse PD-L1 / PD-1 bispecific antibody (mouse IgG2c-LALAPG kappa) was produced in mammalian cells.
Applications: immunohistochemistry (IHC), Flow Cytometry (FC), and various in vitro and in vivo functional assays.
Endotoxin Level: Less than 1 EU/mg of protein as determined by LAL method.

C026P: Nivolumab Biosimilar, PD-1 Monoclonal Antibody

Recombinant Humanized IgG4 Monoclonal Antibody.
Specificity/Sensitivity: The research grade nivolumab biosimilar specifically binds to PD-1, antagonizing its interaction with its known ligands PD-L1 and PD-L2.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by nivolumab.

PA008000.m2cLA: In Vivo Grade Recombinant Anti-mouse PD-1 / PD-1 Bispecific Antibody, Mouse IgG2c LALAPG Kappa (Clone RMP1-14.1 / 29F.1A12.1)

The in vivo grade recombinant anti-mouse PD-1 / PD-1 bispecific antibody (mouse IgG2c-LALAPG kappa) was produced in mammalian cells.
Applications: immunohistochemistry (IHC), Flow Cytometry (FC), and various in vitro and in vivo functional assays.
Endotoxin Level: Less than 1 EU/mg of protein as determined by LAL method.

PA008001.m2cLA: In Vivo Grade Recombinant Anti-mouse PD-1 / PD-1 Bispecific Antibody, Mouse IgG2c LALAPG Kappa (Clone 29F.1A12.1 / RMP1-14.1)

The in vivo grade recombinant anti-mouse PD-1 / PD-1 bispecific antibody (mouse IgG2c-LALAPG kappa) was produced in mammalian cells.
Applications: immunohistochemistry (IHC), Flow Cytometry (FC), and various in vitro and in vivo functional assays.
Endotoxin Level: Less than 1 EU/mg of protein as determined by LAL method.

C023P: Avelumab Biosimilar, PD-L1 Monoclonal Antibody

Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade avelumab biosimilar specifically binds to the programmed death ligand 1 (PD-L1), blocking its interaction with PD-1 and B7-1.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by avelumab.

PA007299.m2a: Non-conjugated Recombinant Anti-human Siglec-2/CD22 Monoclonal Antibody (Clone: NCI m971), Mouse IgG2a kappa

Recombinant  mouse IgG2a monoclonal antibody. 
Conjugation: Non-conjugated.
Specificity/Sensitivity: The recombinant mouse monoclonal antibody (clone: NCI m971) specifically binds to the human Siglec-2/CD22 protein.
Applications: Flow cytometry (FC), and Immunohistochemistry - Frozen (IHC-F). 

PA007299.h1Fs: Non-conjugated Recombinant Anti-human Siglec-2/CD22 Monoclonal Antibody (Clone: NCI m971), Human IgG1 Fc Silent Kappa

Recombinant human IgG1 monoclonal antibody with Fc silent mutation.
Conjugation: Non-conjugated.
Specificity/Sensitivity: The recombinant NCI m971 antibody specifically binds to the human Siglec-2/CD22 protein.
Applications: Flow cytometry (FC), and Immunohistochemistry - Frozen (IHC-F). 

PA007300.h1Fs-b: Biotinylated Recombinant Anti-human Siglec-2/CD22 Monoclonal Antibody (Clone: NCI m971), Human IgG1 Fc Silent Kappa

Recombinant human IgG1 monoclonal antibody with site-directed biotinylation through the Avi tag at the C-terminus of the antibody heavy chain.
Conjugation: Biotin-conjugated.
Specificity/Sensitivity: The site-directed biotinylated recombinant NCI m971 antibody specifically binds to the human Siglec-2/CD22 protein.
Applications: Flow cytometry (FC) with various dye conjugation through streptavidin; conjugation to streptavidin agarose beads or streptavidin magnetic beads.

PA007273.m2a: In vivo Grade Recombinant Anti-human Siglec-2/CD22 Monoclonal Antibody, Mouse IgG2a Kappa (Clone: NCI m971)

Recombinant mouse IgG2a Monoclonal Antibody. 
Specificity/Sensitivity: The in vivo grade recombinant mouse monoclonal antibody (clone: NCI m971) specifically binds to the human Siglec-2/CD22 protein.
Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the human Siglec-2/CD22 protein.